Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02914405
Title Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma (MiniVan)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Hospital Southampton NHS Foundation Trust
Indications

neuroblastoma

Therapies

Dinutuximab beta + Nivolumab

Nivolumab

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.